AI-Powered biopsy test could personalize colorectal cancer treatment

NCT ID NCT07171554

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 27 times

Summary

This study is testing a new diagnostic test called µCAN for people with metastatic colorectal cancer. The test uses a small sample of the tumor and combines it with artificial intelligence to find which drug might work best for each patient. Researchers want to see if the test can successfully produce a report to guide doctors in choosing the right therapy. About 75 adults with cancer that has spread to the liver or abdomen will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER (MCRC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Akershus University Hospital

    RECRUITING

    Lørenskog, Akershus, 1478, Norway

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.